Status:

COMPLETED

Impact of Endothelial Cell Activation and Modifications of Haemostasis Induced by Infective Endocarditis on the Risk of Embolism

Lead Sponsor:

Assistance Publique Hopitaux De Marseille

Conditions:

Infective Endocarditis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Prospective study including all the consecutive patients admitted at the Department of Cardiology, Timone Hospital wih a definite diagnosis of IE according to the modified Duke criteria. The period of...

Eligibility Criteria

Inclusion

  • All the patients presenting certain diagnosis of infectious endocardite according to the criteria of modified Duke

Exclusion

  • Age \< 18 years
  • Pregnancy and feeding
  • Health not allowing to give the assent
  • Innate abnormalities of the haemostasis
  • More than a week before the inclu antibiothérapie adapted begun

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2010

Estimated Enrollment :

77 Patients enrolled

Trial Details

Trial ID

NCT00947817

Start Date

September 1 2008

End Date

April 1 2010

Last Update

August 24 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Département de Cardiologie, Unité Valvulopathies et Insuffisance Cardiaque, Hôpital de la Timone,

Marseille, Paca, France, 13

Impact of Endothelial Cell Activation and Modifications of Haemostasis Induced by Infective Endocarditis on the Risk of Embolism | DecenTrialz